Studies show that 5-amino-1-methylquinolinium injection inhibits NNMT, normalizes nicotinamide metabolism, elevates NAD+, reduces oxidative stress in cells, suppresses apoptosis, preserves cell function, and promotes insulin secretion, supporting longterm glycemic control
Systemic mild symptoms fatigue or drowsiness, headache, lightheadedness, or nausea, typically transient
Shaking introduces mechanical stress and air bubbles that can denature the peptide's structure
It does not stimulate muscle protein synthesis on its own, and it does not act on androgen receptors
Copper balance represents another consideration
If cancer symptoms develop while using GHK-Cu, discontinue use and consult your doctor for evaluation and potential testing